Table 1.
Baseline characteristics (presented as means ± SD and percentages (%)) of the participants in the Malmö Preventive Project Re-examination Study.
| Middle-aged (57-69 years) | Older (70-86 years) | |||||||
|---|---|---|---|---|---|---|---|---|
| Men (N = 11,546) | NFG | IFG | New-onset DM | Established DM | NFG | IFG | New-onset DM | Established DM |
| Number (%) | 4977 (70) | 1299 (18) | 158 (2) | 721 (10) | 3002 (68) | 777 (18) | 85 (2) | 527 (12) |
| Mean age (years) | 64 ± 4 | 64 ± 4 | 63 ± 3 | 65 ± 3 | 75 ± 3 | 75 ± 3 | 74 ± 3 | 75 ± 3 |
| SBP (mmHg) | 143 ± 19 | 150 ± 19 | 157 ± 20 | 148 ± 19 | 145 ± 19 | 152 ± 20 | 151 ± 23 | 148 ± 20 |
| DBP (mmHg) | 84 ± 11 | 88 ± 10 | 90 ± 10 | 84 ± 10 | 83 ± 11 | 85 ± 10 | 86 ± 11 | 81 ± 11 |
| Waist circumference (cm) | 97 ± 10 | 102 ± 11 | 108 ± 12 | 105 ± 12 | 97 ± 10 | 102 ± 10 | 104 ± 9 | 103 ± 11 |
| Total cholesterol (mmol/L) | 5.5 ± 1.0 | 5.6 ± 1.1 | 5.7 ± 1.1 | 4.8 ± 1.1 | 5.4 ± 1.0 | 5.3 ± 1.0 | 5.3 ± 1.0 | 4.7 ± 1.0 |
| LDL (mmol/L) | 3.7 ± 0.9 | 3.7 ± 1.0 | 3.7 ± 1.0 | 3.0 ± 0.9 | 3.5 ± 0.9 | 3.4 ± 0.9 | 3.3 ± 0.9 | 2.9 ± 0.9 |
| HDL (mmol/L) | 1.3 ± 0.4 | 1.2 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.4 ± 0.4 | 1.3 ± 0.4 | 1.3 ± 0.3 | 1.2 ± 0.3 |
| Triglycerides (mmol/L) | 1.2 ± 0.8 | 1.5 ± 1.1 | 2.1 ± 1.6 | 1.7 ± 1.3 | 1.1 ± 0.6 | 1.4 ± 0.8 | 1.7 ± 0.9 | 1.5 ± 0.9 |
| Current smoker (%) | 21.1% | 21.1% | 25.3% | 17.3% | 13.5% | 13.3% | 15.3% | 10.4% |
| Physically inactive (%) | 8.5% | 10.9% | 21.7% | 16.9% | 9.4% | 11.9% | 15.5% | 18.8% |
| Using medication for CVD or HTN (%) | 35% | 44% | 45% | 75% | 53% | 62% | 65% | 84% |
| Women (N = 6680) | ||||||||
| Number (%) | 2979 (84) | 331 (9) | 28 (1) | 202 (6) | 2517 (80) | 333 (11) | 45 (1) | 245 (8) |
| Mean age (years) | 66 ± 4 | 66 ± 3 | 67 ± 2 | 67 ± 3 | 73 ± 3 | 74 ± 3 | 74 ± 3 | 74 ± 3 |
| SBP (mmHg) | 140 ± 20 | 146 ± 20 | 147 ± 23 | 145 ± 21 | 146 ± 21 | 151 ± 22 | 157 ± 24 | 146 ± 20 |
| DBP (mmHg) | 82 ± 10 | 85 ± 11 | 86 ± 9 | 82 ± 10 | 82 ± 10 | 85 ± 11 | 87 ± 11 | 81 ± 10 |
| Waist circumference (cm) | 86 ± 11 | 93 ± 12 | 100 ± 13 | 97 ± 14 | 86 ± 11 | 93 ± 12 | 97 ± 11 | 96 ± 13 |
| Total cholesterol (mmol/L) | 6.0 ± 1.0 | 6.0 ± 1.0 | 6.2 ± 1.4 | 5.3 ± 1.1 | 6.0 ± 1.1 | 5.9 ± 1.1 | 6.2 ± 1.2 | 5.1 ± 1.0 |
| LDL (mmol/L) | 3.9 ± 1.0 | 3.9 ± 0.9 | 4.1 ± 1.3 | 3.2 ± 0.9 | 3.8 ± 1.0 | 3.7 ± 1.0 | 4.0 ± 1.0 | 3.0 ± 0.9 |
| HDL (mmol/L) | 1.6 ± 0.4 | 1.4 ± 0.4 | 1.2 ± 0.3 | 1.4 ± 0.4 | 1.7 ± 0.4 | 1.5 ± 0.5 | 1.3 ± 0.4 | 1.4 ± 0.4 |
| Triglycerides (mmol/L) | 1.1 ± 0.6 | 1.5 ± 0.7 | 2.1 ± 0.9 | 1.6 ± 1.6 | 1.2 ± 0.5 | 1.4 ± 0.7 | 1.8 ± 0.9 | 1.6 ± 0.9 |
| Current smoker (%) | 18.5% | 21.1% | 21.4% | 14.4% | 12.2% | 15.3% | 11.1% | 11.4% |
| Physically inactive (%) | 8.0% | 11.3% | 21.4% | 19.3% | 11.5% | 20.4% | 27.3% | 20.4% |
| Using medication for CVD or HTN (%) | 32% | 51% | 54% | 69% | 48% | 59% | 49% | 82% |
NFG, normal fasting glucose; IFG, impaired fasting glucose; DM, diabetes mellitus; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein, LDL, low-density lipoprotein; HDL, high-density lipoprotein; CVD, cardiovascular disease; HTN, hypertension.